Bansal N - Search Results

1

Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.

Kimani SG, Kumar S, Bansal N, Singh K, Kholodovych V, Comollo T, Peng Y, Kotenko SV, Sarafianos SG, Bertino JR, Welsh WJ, Birge RB. Kimani SG, et al. Among authors: bansal n. Sci Rep. 2017 Mar 8;7:43908. doi: 10.1038/srep43908. Sci Rep. 2017. PMID: 28272423 Free PMC article.

2

Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells.

Bansal N, Mishra PJ, Stein M, DiPaola RS, Bertino JR. Bansal N, et al. Oncotarget. 2015 Jun 20;6(17):15321-31. doi: 10.18632/oncotarget.4148. Oncotarget. 2015. PMID: 26036314 Free PMC article.

3

A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts.

Xie X, Bansal N, Shaik T, Kerrigan JE, Minko T, Garbuzenko O, Abali EE, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. Xie X, et al. Among authors: bansal n. Oncotarget. 2014 Feb 28;5(4):901-7. doi: 10.18632/oncotarget.1809. Oncotarget. 2014. PMID: 24658650 Free PMC article.

4

Darinaparsin inhibits prostate tumor-initiating cells and Du145 xenografts and is an inhibitor of hedgehog signaling.

Bansal N, Farley NJ, Wu L, Lewis J, Youssoufian H, Bertino JR. Bansal N, et al. Mol Cancer Ther. 2015 Jan;14(1):23-30. doi: 10.1158/1535-7163.MCT-13-1040. Epub 2014 Nov 7. Mol Cancer Ther. 2015. PMID: 25381261

5

BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.

Bansal N, Bartucci M, Yusuff S, Davis S, Flaherty K, Huselid E, Patrizii M, Jones D, Cao L, Sydorenko N, Moon YC, Zhong H, Medina DJ, Kerrigan J, Stein MN, Kim IY, Davis TW, DiPaola RS, Bertino JR, Sabaawy HE. Bansal N, et al. Clin Cancer Res. 2016 Dec 15;22(24):6176-6191. doi: 10.1158/1078-0432.CCR-15-3107. Epub 2016 Jun 15. Clin Cancer Res. 2016. PMID: 27307599 Free PMC article.

6

Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer.

Shaik T, Rather GM, Bansal N, Minko T, Garbuzenko O, Szekely Z, Abali EE, Banerjee D, Kerrigan JE, Scotto KW, Bertino JR. Shaik T, et al. Among authors: bansal n. Oncotarget. 2018 Sep 7;9(70):33249-33257. doi: 10.18632/oncotarget.26064. eCollection 2018 Sep 7. Oncotarget. 2018. PMID: 30279956 Free PMC article.

7

NAD+ Kinase as a Therapeutic Target in Cancer.

Tedeschi PM, Bansal N, Kerrigan JE, Abali EE, Scotto KW, Bertino JR. Tedeschi PM, et al. Among authors: bansal n. Clin Cancer Res. 2016 Nov 1;22(21):5189-5195. doi: 10.1158/1078-0432.CCR-16-1129. Epub 2016 Aug 31. Clin Cancer Res. 2016. PMID: 27582489 Review.

8

Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion.

Bansal N, Davis S, Tereshchenko I, Budak-Alpdogan T, Zhong H, Stein MN, Kim IY, Dipaola RS, Bertino JR, Sabaawy HE. Bansal N, et al. Prostate. 2014 Feb;74(2):187-200. doi: 10.1002/pros.22740. Epub 2013 Oct 24. Prostate. 2014. PMID: 24154958 Free PMC article.

9

Species-specific differences in translational regulation of dihydrofolate reductase.

Hsieh YC, Skacel NE, Bansal N, Scotto KW, Banerjee D, Bertino JR, Abali EE. Hsieh YC, et al. Among authors: bansal n. Mol Pharmacol. 2009 Oct;76(4):723-33. doi: 10.1124/mol.109.055772. Epub 2009 Jul 1. Mol Pharmacol. 2009. PMID: 19570950 Free PMC article.

10

Tumor initiating cells.

Bansal N, Banerjee D. Bansal N, et al. Curr Pharm Biotechnol. 2009 Feb;10(2):192-6. doi: 10.2174/138920109787315015. Curr Pharm Biotechnol. 2009. PMID: 19199951 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,130 results

Search Page